Listed Nigerian Drugmakers Raise Factory and Equipment Spending to ₦29.26 Billion
Five publicly listed Nigerian pharmaceutical manufacturers invested a combined ₦29.26 billion in factories, machinery and production infrastructure during the first nine months of 2026, according to an analysis of their published financial statements.
The figure represents an increase of about 81 per cent compared with the corresponding period a year earlier. The companies covered were Fidson Healthcare, May & Baker Nigeria, Neimeth International Pharmaceuticals, Pharma-Deko and Morison Industries.
Why the investment matters
Nigeria continues to rely heavily on imported medicines, active pharmaceutical ingredients and specialised production equipment. Additional local manufacturing capacity could improve supply resilience and reduce some exposure to foreign-exchange shortages, although new spending does not automatically translate into cheaper medicines.
The expenditure includes new production facilities, machinery and upgrades intended to meet higher manufacturing standards. Fidson has been developing a World Health Organization-compliant good-manufacturing-practice facility in Amawbia, Anambra State, while also upgrading its Oregun operation in Lagos.
The investment comes alongside federal measures supporting local production. Recent government reporting said pharmaceutical manufacturers had received tariff and tax relief on machinery, ingredients and production materials.
Results will depend on execution
Capital expenditure is an indicator of investment, not proof that every project is complete or commercially operational. The effect on medicine availability will depend on commissioning, regulatory approval, reliable electricity, access to raw materials and the companies’ ability to distribute products efficiently.
MBTV will continue to track whether the investments lead to increased local output and measurable improvements in medicine supply.
Sources: Financial-statement analysis reported by BusinessDay; Background on federal manufacturing incentives.
Featured image: licensed illustrative production-line photograph.
